+ All Categories
Home > Documents > CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass...

CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass...

Date post: 27-May-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
16
bulk sku: RSO product name: 100MG RSO 1 g = 10 kg = 10 mg = 10 µg 1 mg/kg = 1 ppm = 1000 ppb 1. American Herbal Pharmacopoeia. (2014). Cannabis Inflorescence: Standards of Identity, Analysis, and Quality Control. Washington DC: AHP. 2. US Food and Drug Administration. (2019). Lead in Food, Foodwares, and Dietary Supplements. Washington DC: FDA.US Food and Drug Administration. (2019). Lead in Food, Foodwares, and Dietary Supplements. Washington DC: FDA. NR: Not Reported NA: Not Available LOQ: Limit Of Quantitation LOD: Limit Of Detection - 3 6 3 Heavy Metals Per Gram Arsenic N/A µg/day Regulatory Action Level Pesticides Potency Cadmium µg/day Lead µg/day Mercury µg/day 10 Cannabidiol (CBD) None of the 59 pesticides tested found above limit of detection in the sample. 10 Regulatory Action Level N/A mg/g ppb [1] [2] [1] [1] [1] Cannabichromene (CBC) Cannabinol (CBN) Cannabigerol (CBG) Total THC (d9-THC + d8-THC) N/A N/A µg/serving Per Serving Per Serving µg/g mg/g mg/g mg/g mg/g mg/g mg/serving mg/serving mg/serving mg/serving mg/serving BATCH #: CA18 lab name: Pixis Labs Oregon Accreditation: OR100028 Per Gram 55.5 1.34 0.785 0.036 2.14 109.76 4.22 0.07 1.55 2.65 3 4.1 2 3.5 <LOQ <LOQ CONSOLIDATED TEST RESULTS SUMMARY Please see the following pages for full test results. <LOQ <LOQ <LOQ µg/serving µg/serving µg/serving <LOQ <LOQ <LOQ µg/g µg/g µg/g Regulatory Action Level residual solvents None of the 36 residual solvents tested found above limit of detection in the sample. microbial Pass/Fail Yeast & Mold Coliform Pass Pass Terpenes % of sample Farnesene ß-Caryophyllene a-Bisabolol Terpenes % of sample Guaiol Humulene 0.158% 0.171% 0.0742% 0.0229% 0.0770% Caryophyllene Oxide 0.0436%
Transcript
Page 1: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

bulk sku: RSO

product name: 100MG RSO

1 g = 10 kg = 10 mg = 10 µg 1 mg/kg = 1 ppm = 1000 ppb

1. American Herbal Pharmacopoeia. (2014). Cannabis Inflorescence: Standards of Identity, Analysis, and Quality Control. Washington DC: AHP.2. US Food and Drug Administration. (2019). Lead in Food, Foodwares, and Dietary Supplements. Washington DC: FDA.US Food and Drug Administration. (2019). Lead in Food, Foodwares, and Dietary Supplements. Washington DC: FDA.

NR: Not Reported NA: Not Available

LOQ: Limit Of Quantitation LOD: Limit Of Detection

-3 6 3

Heavy Metals Per Gram

Arsenic

N/A

µg/day

Regulatory Action Level

Pesticides

Potency

Cadmium µg/day

Lead µg/day

Mercury µg/day

10

Cannabidiol (CBD)

None of the 59 pesticides tested found above limit of detection in the sample. 10

Regulatory Action Level

N/A

mg/g

ppb

[1]

[2]

[1]

[1]

[1]

Cannabichromene (CBC)

Cannabinol (CBN)

Cannabigerol (CBG)

Total THC (d9-THC + d8-THC)

N/A

N/A

µg/serving

Per Serving

Per Serving

µg/g

mg/g

mg/g

mg/g

mg/g

mg/gmg/serving

mg/serving

mg/serving

mg/serving

mg/serving

BATCH #: CA18

lab name: Pixis Labs Oregon Accreditation: OR100028

Per Gram

55.5

1.34

0.785

0.036

2.14

109.76

4.22

0.07

1.55

2.65 3

4.1

2

3.5

<LOQ <LOQ

CONSOLIDATED TEST RESULTS SUMMARYPlease see the following pages for full test results.

<LOQ

<LOQ

<LOQ

µg/serving

µg/serving

µg/serving

<LOQ

<LOQ

<LOQ

µg/g

µg/g

µg/g

Regulatory Action Level

residual solvents

None of the 36 residual solvents tested found above limit of detection in the sample.

microbial Pass/Fail

Yeast & Mold

Coliform

Pass

Pass

Terpenes % of sample

Farnesene

ß-Caryophyllene

a-Bisabolol

Terpenes % of sample

Guaiol

Humulene

0.158%

0.171%

0.0742%

0.0229%

0.0770%

Caryophyllene Oxide 0.0436%

Page 2: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/21/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D01.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0002Laboratory ID:

Etz Hayim Holdings

SummaryPotency:

Units StatusResult Limits

4.27 mg/1ml111 mg/1ml0.461 mg/1ml1.57 mg/1ml0.186 mg/1ml0.0713 mg/1ml2.68

Analyte per 1mlCBC per 1ml†

CBD per 1ml CBDV per 1ml†

CBG per 1ml†

CBL per 1ml†

CBN per 1ml∆9-THC per 1ml mg/1ml

111 mg/1mlCBD-Total per 1ml

2.68 mg/1mlTHC-Total per 1ml

(Reported in milligrams per serving)

Page 1 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 3: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/21/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D01.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0002Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

1.011 gServing Size #1:

Sample Results

Batch: 2000595Potency per 1mlUnits LOQ Analyze NotesMethodResult Limits

J AOAC 2015 V98-601/21/204.27 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/204.27 0.0633

J AOAC 2015 V98-601/21/20111 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/20111 0.0633

J AOAC 2015 V98-601/21/200.461 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/200.461 0.0629

J AOAC 2015 V98-601/21/201.57 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/201.57 0.0633

J AOAC 2015 V98-601/21/200.186 0.0337

J AOAC 2015 V98-601/21/200.0713 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/202.68 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/202.68 0.0633

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0337

J AOAC 2015 V98-601/21/20< LOQ 0.0629

Page 2 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Analyte

CBC per 1ml†

CBC-A per 1ml†

CBC-Total per 1ml†

CBD per 1mlCBD-A per 1ml CBD-Total per 1ml CBDV per 1ml†

CBDV-A per 1ml†

CBDV-Total per 1ml†

CBG per 1ml†

CBG-A per 1ml†

CBG-Total per 1ml†

CBL per 1ml†

CBN per 1ml∆8-THC per 1ml†

∆9-THC per 1ml THC-A per 1ml THC-Total per 1ml THCV per 1ml†

THCV-A per 1ml†

THCV-Total per 1ml†

mg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1mlmg/1ml

Page 4: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D07.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0007Laboratory ID:

Etz Hayim Holdings

SummaryMetals:Less than LOQ for all analytes.

Page 1 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with:

Page 5: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D07.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0007Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

Sample Results

MetalsUnits LOQ Analyze NotesMethodAnalyte BatchResult Limits

AOAC 2013.06 (mod.)mg/kg 01/27/20 X2000802< LOQ 0.0378Arsenic

AOAC 2013.06 (mod.)mg/kg 01/27/20 X2000802< LOQ 0.0378Cadmium

AOAC 2013.06 (mod.)mg/kg 01/27/20 X2000802< LOQ 0.0378Lead

AOAC 2013.06 (mod.)mg/kg 01/27/20 X2000802< LOQ 0.0189Mercury

Page 2 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with:

Page 6: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D02.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0001Laboratory ID:

Etz Hayim Holdings

SummaryPesticides:All analytes passing and less than LOQ.

Page 1 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0400

Page 7: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D02.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0001Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

Sample Results

Pesticides Batch 2000472Method AOAC 2007.01 & EN 15662 (mod) Units mg/kg Analyze 01/16/20 04:51 PM

LOQAnalyte Result Limits Status Notes LOQAnalyte Result Limits Status Notes

< LOQ 0.50 passAbamectin 0.250 < LOQ 0.40 passAcephate 0.250

< LOQ 2.0 passAcequinocyl 1.00 < LOQ 0.20 passAcetamiprid 0.100

< LOQ 0.40 passAldicarb 0.200 < LOQ 0.20 passAzoxystrobin 0.100

< LOQ 0.20 passBifenazate 0.100 < LOQ 0.20 passBifenthrin 0.100

< LOQ 0.40 passBoscalid 0.200 < LOQ 0.20 passCarbaryl 0.100

< LOQ 0.20 passCarbofuran 0.100 < LOQ 0.20 passChlorantraniliprole 0.100

< LOQ 1.0 passChlorfenapyr 0.500 < LOQ 0.20 passChlorpyrifos 0.100

< LOQ 0.20 passClofentezine 0.100 < LOQ 1.0 passCyfluthrin 0.500

< LOQ 1.0 passCypermethrin 0.500 < LOQ 1.0 passDaminozide 0.500

< LOQ 0.20 passDiazinon 0.100 < LOQ 1.0 passDichlorvos 0.500

< LOQ 0.20 passDimethoate 0.100 < LOQ 0.20 passEthoprophos 0.100

< LOQ 0.40 passEtofenprox 0.200 < LOQ 0.20 passEtoxazole 0.100

< LOQ 0.20 passFenoxycarb 0.100 < LOQ 0.40 passFenpyroximate 0.200

< LOQ 0.40 passFipronil 0.200 < LOQ 1.0 passFlonicamid 0.400

< LOQ 0.40 passFludioxonil 0.200 < LOQ 1.0 passHexythiazox 0.400

< LOQ 0.20 passImazalil 0.100 < LOQ 0.40 passImidacloprid 0.200

< LOQ 0.40 passKresoxim-methyl 0.200 < LOQ 0.20 passMalathion 0.100

< LOQ 0.20 passMetalaxyl 0.100 < LOQ 0.20 passMethiocarb 0.100

< LOQ 0.40 passMethomyl 0.200 < LOQ 0.20 passMGK-264 0.100

< LOQ 0.20 passMyclobutanil 0.100 < LOQ 0.50 passNaled 0.250

< LOQ 1.0 passOxamyl 0.500 < LOQ 0.40 passPaclobutrazole 0.200

< LOQ 0.20 passParathion-Methyl 0.200 < LOQ 0.20 passPermethrin 0.100

< LOQ 0.20 passPhosmet 0.100 < LOQ 2.0 passPiperonyl butoxide 1.00

< LOQ 0.20 passPrallethrin 0.200 < LOQ 0.40 passPropiconazole 0.200

< LOQ 0.20 passPropoxur 0.100 < LOQ 1.0 passPyrethrin I (total) 0.500

< LOQ 0.20 passPyridaben 0.100 < LOQ 0.20 passSpinosad 0.100

< LOQ 0.20 passSpiromesifen 0.100 < LOQ 0.20 passSpirotetramat 0.100

< LOQ 0.40 passSpiroxamine 0.200 < LOQ 0.40 passTebuconazole 0.200

< LOQ 0.20 passThiacloprid 0.100 < LOQ 0.20 passThiamethoxam 0.100

< LOQ 0.20 passTrifloxystrobin 0.100

Page 2 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0400

Page 8: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D03.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0003Laboratory ID:

Etz Hayim Holdings

SummaryResidual Solvents:All analytes passing and less than LOQ.

Page 1 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0410

Page 9: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D03.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0003Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

Sample Results

Solvents Batch 2000708Method EPA5021A Units µg/g Analyze 01/24/20 09:05 AM

LOQAnalyte Result Limits Status Notes LOQAnalyte Result Limits Status Notes

< LOQ 380 pass1,4-Dioxane 100 < LOQ 5000 pass2-Butanol 200

< LOQ 160 pass2-Ethoxyethanol 30.0 < LOQ2-Methylbutane 200

< LOQ2-Methylpentane 30.0 < LOQ 5000 pass2-Propanol (IPA) 200

< LOQ2,2-Dimethylbutane 30.0 < LOQ2,2-Dimethylpropane 200

< LOQ2,3-Dimethylbutane 30.0 < LOQ3-Methylpentane 30.0

< LOQ 5000 passAcetone 200 < LOQ 410 passAcetonitrile 100

< LOQ 2.00 passBenzene 1.00 < LOQ 5000 passButanes (sum) 400

< LOQ 3880 passCyclohexane 200 < LOQ 5000 passEthyl acetate 200

< LOQEthyl benzene 200 < LOQ 5000 passEthyl ether 200

< LOQ 620 passEthylene glycol 200 < LOQ 50.0 passEthylene oxide 30.0

< LOQ 290 passHexanes (sum) 150 < LOQ 5000 passIsopropyl acetate 200

< LOQ 70.0 passIsopropylbenzene 30.0 < LOQm,p-Xylene 200

< LOQ 3000 passMethanol 200 < LOQ 600 passMethylene chloride 200

< LOQMethylpropane 200 < LOQn-Butane 200

< LOQ 5000 passn-Heptane 200 < LOQn-Hexane 30.0

< LOQn-Pentane 200 < LOQo-Xylene 200

< LOQ 5000 passPentanes (sum) 600 < LOQ 5000 passPropane 200

< LOQ 720 passTetrahydrofuran 100 < LOQ 890 passToluene 100

< LOQTotal Xylenes 400 < LOQ 2170 passTotal Xylenes and Ethyl 600

Page 2 of 7Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0410

Page 10: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D05.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0005Laboratory ID:

Etz Hayim Holdings

SummaryMicrobiology:Less than LOQ for all analytes.

Page 1 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0390

Page 11: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D05.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0005Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

Sample Results

MicrobiologyUnits LOQ Analyze NotesMethodAnalyte BatchResult Limits

AOAC 2014.05 (RAPID)cfu/g 01/26/20 X2000707< LOQ 10Mold (RAPID Petrifilm)

AOAC 2014.05 (RAPID)cfu/g 01/26/20 X2000707< LOQ 10Yeast (RAPID Petrifilm)

Page 2 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0390

Page 12: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D06.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0006Laboratory ID:

Etz Hayim Holdings

SummaryMicrobiology:Less than LOQ for all analytes.

Page 1 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0390

Page 13: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D06.R00

Customer: Etz Hayim Holdings

Product identity: CA18 RSO

01/10/20Sample Date:

20-000513-0006Laboratory ID:

Client/Metrc ID: .

Brian RamosRelinquished by:

19.5 °CTemp:

Sample Results

MicrobiologyUnits LOQ Analyze NotesMethodAnalyte BatchResult Limits

AOAC 991.14 (Petrifilm)cfu/g 01/26/20 X2000705< LOQ 10E.coli

AOAC 991.14 (Petrifilm)cfu/g 01/26/20 X2000705< LOQ 10Total Coliforms

Page 2 of 5Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0390

Page 14: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D04.R00

Product identity: CA18 RSO

Client/Metrc ID: .

Customer:

01/10/20Sample Date:20-000513-0004Laboratory ID:

Etz Hayim Holdings

SummaryTerpenes:

Analyte Percentby weight

Percentof Total

Analyte Percentby weight

Percentof Total

0.171ß-Caryophyllene† 31.26% 0.158farnesene† 28.88%

0.0770Humulene† 14.08% 0.0742a-Bisabolol† 13.56%

0.0436(-)-caryophyllene oxide† 7.97% 0.0229(-)-Guaiol† 4.19%

0.547Total Terpenes† 100.00%

Page 1 of 9Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with:

Page 15: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D04.R00

Terpenes Batch 2000723Method J AOAC 2015 V98-6 Units % Analyze 01/24/20 09:54 AM

LOQAnalyte Result Notes% of Total LOQAnalyte Result Notes% of Total

0.171ß-Caryophyllene† 31.26%0.020 0.158farnesene† 28.88%0.020

0.0770Humulene† 14.08%0.020 0.0742a-Bisabolol† 13.56%0.020

0.0436(-)-caryophyllene oxide† 7.97%0.020 0.0229(-)-Guaiol† 4.19%0.020

< LOQ(±)-trans-Nerolidol† 0.00%0.020 < LOQ(-)-a-Terpineol† 0.00%0.020

< LOQ(-)-Isopulegol† 0.00%0.020 < LOQ(-)-ß-Pinene† 0.00%0.020

< LOQ(+)-Borneol† 0.00%0.020 < LOQ(+)-Cedrol† 0.00%0.020

< LOQ(+)-fenchol† 0.00%0.020 < LOQ(+)-Pulegone† 0.00%0.020

< LOQ(±)-Camphor† 0.00%0.020 < LOQ(±)-cis-Nerolidol† 0.00%0.020

< LOQ(±)-fenchone† 0.00%0.020 < LOQ(R)-(+)-Limonene† 0.00%0.020

< LOQa-cedrene† 0.00%0.020 < LOQa-phellandrene† 0.00%0.020

< LOQa-pinene† 0.00%0.020 < LOQa-Terpinene† 0.00%0.020

< LOQCamphene† 0.00%0.020 < LOQcis-ß-Ocimene† 0.00%0.006

< LOQd-3-Carene† 0.00%0.020 < LOQEucalyptol† 0.00%0.020

< LOQgamma-Terpinene† 0.00%0.020 < LOQGeraniol† 0.00%0.020

< LOQGeranyl acetate† 0.00%0.020 < LOQIsoborneol† 0.00%0.020

< LOQLinalool† 0.00%0.020 < LOQMenthol† 0.00%0.020

< LOQnerol† 0.00%0.020 < LOQp-Cymene† 0.00%0.020

< LOQSabinene† 0.00%0.020 < LOQSabinene hydrate† 0.00%0.020

< LOQß-Myrcene† 0.00%0.020 < LOQTerpinolene† 0.00%0.020

< LOQtrans-ß-Ocimene† 0.00%0.013 < LOQvalencene† 0.00%0.020

Total Terpenes 0.547

ß-C

aryo

phyl

lene

farn

esen

e

Hum

ulen

e

a-B

isab

olol

(-)-

cary

ophy

llene

ox

ide

(-)-

Gua

iol

%

Page 3 of 9Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with:

Page 16: CONSOLIDATED TEST RESULTS SUMMARY bulk sku RSO BATCH ... · Oxamyl < LOQ 1.0 0.500 pass Paclobutrazole < LOQ 0.40 0.200 pass Parathion-Methyl < LOQ 0.20 0.200 pass Permethrin < LOQ

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

01/28/2020

OR100028

09:15Received: 01/14/20

Purchase Order:

20-000513/D04.R00

31.26 %ß-Caryophyllene

28.88 %farnesene

14.08 %Humulene

13.56 %a-Bisabolol

7.97 %(-)-caryophyllene oxide

4.19 %(-)-Guaiol

Page 4 of 9Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with:


Recommended